0001140361-17-018903.txt : 20170508
0001140361-17-018903.hdr.sgml : 20170508
20170508173045
ACCESSION NUMBER: 0001140361-17-018903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170504
FILED AS OF DATE: 20170508
DATE AS OF CHANGE: 20170508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INTREXON CORP
CENTRAL INDEX KEY: 0001356090
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 17823615
BUSINESS ADDRESS:
STREET 1: 1750 KRAFT DRIVE
STREET 2: SUITE 1400
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 301-556-9809
MAIL ADDRESS:
STREET 1: 1750 KRAFT DRIVE
STREET 2: SUITE 1400
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRK RANDAL J
CENTRAL INDEX KEY: 0001091823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 17823616
MAIL ADDRESS:
STREET 1: 1881 GROVE AVENUE
CITY: RADFORD
STATE: VA
ZIP: 24141
4
1
doc1.xml
FORM 4
X0306
4
2017-05-04
1
0000812796
SOLIGENIX, INC.
SNGX
0001091823
KIRK RANDAL J
C/O THIRD SECURITY, LLC
1881 GROVE AVENUE
RADFORD
VA
24141
0
0
1
0
0001356090
INTREXON CORP
C/O LEGAL DEPARTMENT
20374 SENECA MEADOWS PARKWAY
GERMANTOWN
MD
20876
0
0
1
0
Common Stock
2017-05-04
4
X
0
250000
0.80
A
583334
I
by NRM VII Holdings
Common Stock
2017-05-04
4
S
0
49875
4.01
D
533459
I
by NRM VII Holdings
Common Stock
2017-05-04
4
S
0
11739
2.97
D
521720
I
by NRM VII Holdings
Common Stock
2017-05-05
4
S
0
71607
2.70
D
450113
I
by NRM VII Holdings
Common Stock
2017-05-08
4
S
0
9695
2.54
D
440418
I
by NRM VII Holdings
Common Stock
2017-05-04
4
S
0
2278
2.97
D
101171
I
by Intrexon
Common Stock
2017-05-05
4
S
0
13893
2.70
D
87278
I
by Intrexon
Common Stock
2017-05-08
4
S
0
1881
2.54
D
85397
I
by Intrexon
Warrant to Purchase Common Stock
0.80
2017-05-04
4
X
0
250000
0
D
2013-06-25
2018-06-25
Common Stock
250000
0
I
by NRM VII Holdings
The indicated share amount is reflective of a 1:10 reverse stock split effected by the issuer on October 7, 2016.
Shares surrendered to the issuer in order to satisfy the exercise price in connection with the cashless exercise of a warrant to purchase 250,000 shares of common stock of the issuer.
Pursuant to a joint selling program, NRM VII Holdings I, LLC ("NRM VII Holdings") and Intrexon Corporation ("Intrexon") sold shares on a pro rata basis.
Randal J. Kirk controls NRM VII Holdings. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d- 3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon. Shares held by Intrexon may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
/s/ Randal J. Kirk
2017-05-08
/s/ Randal J. Kirk, CEO of Intrexon Corporation
2017-05-08